Dukat M - Search Results

1

Computational analysis of non-competitive antagonist arylguanidine-α7 nAChR complexes.

Alwassil OI, Abdrakhmanova GR, Dukat M. Alwassil OI, et al. Among authors: dukat m. J Mol Graph Model. 2021 Sep;107:107943. doi: 10.1016/j.jmgm.2021.107943. Epub 2021 May 22. J Mol Graph Model. 2021. PMID: 34058639

2

Aryloxyethylamines: binding at alpha7 nicotinic acetylcholine receptors.

Ragab HM, Kim JS, Dukat M, Navarro H, Glennon RA. Ragab HM, et al. Among authors: dukat m. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4283-6. doi: 10.1016/j.bmcl.2006.05.080. Epub 2006 Jun 9. Bioorg Med Chem Lett. 2006. PMID: 16765047

3

MD-354 selectively antagonizes the antinociceptive effects of (-)nicotine in the mouse tail-flick assay.

Dukat M, Wesołowska A, Alley G, Young S, Abdrakhmanova GR, Navarro HA, Young R, Glennon RA. Dukat M, et al. Psychopharmacology (Berl). 2010 Jul;210(4):547-57. doi: 10.1007/s00213-010-1857-0. Epub 2010 Apr 30. Psychopharmacology (Berl). 2010. PMID: 20431995

4

"Methylene Bridge" to 5-HT₃ Receptor Antagonists: Conformationally Constrained Phenylguanidines.

Abdelkhalek AS, Alley GS, Alwassil OI, Khatri S, Mosier PD, Nyce HL, White MM, Schulte MK, Dukat M. Abdelkhalek AS, et al. Among authors: dukat m. ACS Chem Neurosci. 2019 Mar 20;10(3):1380-1389. doi: 10.1021/acschemneuro.8b00431. Epub 2018 Nov 8. ACS Chem Neurosci. 2019. PMID: 30375852

5

N₁H- and N₁-Substituted Phenylguanidines as α7 Nicotinic Acetylcholine (nACh) Receptor Antagonists: Structure-Activity Relationship Studies.

Alwassil OI, Khatri S, Schulte MK, Aripaka SS, Mikkelsen JD, Dukat M. Alwassil OI, et al. Among authors: dukat m. ACS Chem Neurosci. 2021 Jun 16;12(12):2194-2201. doi: 10.1021/acschemneuro.1c00212. Epub 2021 May 27. ACS Chem Neurosci. 2021. PMID: 34043311

6

The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.

Glennon RA, Dukat M, Westkaemper RB, Ismaiel AM, Izzarelli DG, Parker EM. Glennon RA, et al. Among authors: dukat m. Mol Pharmacol. 1996 Jan;49(1):198-206. Mol Pharmacol. 1996. PMID: 8569707

7

Central nicotinic receptor ligands and pharmacophores.

Glennon RA, Dukat M. Glennon RA, et al. Among authors: dukat m. Pharm Acta Helv. 2000 Mar;74(2-3):103-14. doi: 10.1016/s0031-6865(99)00022-9. Pharm Acta Helv. 2000. PMID: 10812946 Review.

8

A comparison of the binding of three series of nicotinic ligands.

Lee M, Dukat M, Liao L, Flammia D, Damaj MI, Martin B, Glennon RA. Lee M, et al. Among authors: dukat m. Bioorg Med Chem Lett. 2002 Aug 5;12(15):1989-92. doi: 10.1016/s0960-894x(02)00298-6. Bioorg Med Chem Lett. 2002. PMID: 12113825

9

Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors.

Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA. Ferretti G, et al. Among authors: dukat m. Bioorg Med Chem Lett. 2003 Feb 24;13(4):733-5. doi: 10.1016/s0960-894x(02)01031-4. Bioorg Med Chem Lett. 2003. PMID: 12639569

10

Epibatidine: impact on nicotinic receptor research.

Dukat M, Glennon RA. Dukat M, et al. Cell Mol Neurobiol. 2003 Jun;23(3):365-78. doi: 10.1023/a:1023692705700. Cell Mol Neurobiol. 2003. PMID: 12825833 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page